Kaia Health Announces Industry-First Partnership with Luna

To Support Mission of Access to High-Quality Musculoskeletal Care

Kaia Health, the next-generation solution for musculoskeletal (MSK) care covering 60 million lives globally, has unveiled an industry-first partnership with Luna On-Demand Physical Therapy to further extend access to high-quality care for MSK patients by delivering physical therapy to a patient’s doorstep.

This unique online-offline partnership will expand access to care for more members, including high-risk patients, and advance the Kaia Health mission to make effective therapies accessible to patients anywhere and at any time. Using a multimodal approach, Kaia Health provides a holistic MSK pain rehabilitation program that reduces the likelihood of inconsistencies, incomplete care, and duplicative services.

Kaia Health is now the only digital MSK pain solution to provide clinically validated digital therapy complemented by in-person, at-home intervention at the right points in a patient’s care journey.

“While Kaia Health digital therapy is the best, most accessible MSK pain solution for the vast majority of patients, some with recent orthopedic trauma, for example, will benefit from in-person physical therapy to significantly improve chances for a positive outcome and avoid surgery,” said Kim Clarno, DPT, Director of Clinical Experience at Kaia Health.

In addition to expanding care accessibility for more members, the partnership enables a simple, integrated patient journey. Eligible members can schedule physical therapy at home or work, so receiving care is safe, convenient, and typically faster than scheduling in-clinic care. For care consistency and continuity, patients can work with the same specialized physical therapist for every appointment, achieving an integrated care experience between their in-person therapy and the Kaia Health program.

Clinical studies show that therapeutic exercise combined with hands-on physical therapy provides beneficial outcomes for patients by reducing pain or avoiding invasive surgery.

Integrating the Luna physical therapy service is the latest addition to Kaia Health’s clinically optimized MSK care pathway, which consists of live human coaching; tele-consultations with physical therapists; proprietary computer vision technology for exercise feedback with progress monitoring; and an expert, in-house medical review team.

“This partnership represents a major leap forward in our mission to make high-quality care accessible to all patients—wherever they are in their journey—and deliver the best outcomes,” said Konstantin Mehl, Kaia Health CEO and Founder. “Partnering with Luna furthers our lead in the MSK market and extends our human-centered, digitally enabled approach to managing MSK conditions.”

“Partnering with Kaia Health is consistent with our philosophy of using digital care when appropriate and as an entry point for structured, in-person MSK pain therapy according to patient need,” said Palak Shah, Luna co-founder and head of clinical services. “With Luna, Kaia Health solves accessibility issues by bringing physical therapy to members at home, on their own schedule. Delivering personalized and effective therapy in this way maximizes engagement and patient outcomes.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version